![]() | Only 14 pages are availabe for public view |
Abstract Breast cancer is one of the most common types of cancer. Despite major advances in mammography, at least 10-20% of breast cancers can go undetected using screening mammography alone. The accuracy of mammography is especially limited in dense breasts where the surrounding fibroglandular tissue decreases the conspicuity of the lesions. Even when lesions are detected the full extent of the disease may not be clearly depicted. Ultrasound is a complementary technique for mammography especially for dense breasts, but US examinations are time consuming and operator dependant. Contrast-enhanced MRI is currently the most sensitive breast cancer detection technique, though it has high false positive rate and still carries the burden of high cost and low availability. Various techniques are being developed to minimize the risk of overlooking lesions in women with dense breasts. CEDM is a new technique, currently under evaluation to determine the best indications for it and to assess its possible diagnostic benefits. CEDM has the advantage of being a fast imaging technique, which can be performed by using a current digital mammography system with some specific software and hardware adaptations and has the advantage of being reproducible without operator dependency Between the two techniques of CEDM currently being investigated (the temporal subtraction technique and the dualenergy technique), the dual-energy technique offers the possibility of imaging both breasts in two views (CC and MLO) during a single injection of contrast, less sensitive to patient motion and better tolerated by the patient due to shorter examination and breast compression time. Studies demonstrate that there can be a diagnostic gain achieved by combining dual-energy CEDM with conventional mammography especially in women with dense breasts. Some tumors were only detected with the help of contrast mammography. Compared to the standard of care for diagnostic procedures (mammography associated with breast ultrasound), CEDM had a better diagnostic accuracy due to improved sensitivity and due to the significant reduction in the number of false negatives compared to mammography alone. We note that it’s still difficult to differentiate between benign and malignant tumors on basis of enhancement, as is usual in MRI, which may be improved in the future with the development of standardized diagnostic criteria and imaging protocols for CEDM. Studies hint that similar to breast MRI, CEDM could be of particular interest for the assessment of the local extent of the disease. Actually in our study, dual-energy CEDM detected multifocal breast cancers in all cases and allowed more accurate lesion size evaluation. In conclusion CEDM has the potential to increase the cancer detection rate, to improve staging and to improve the selection of patients for biopsy. Moreover it can be used for better assessment of recurrent disease and for monitoring of the response to chemotherapy. |